Investing.com - Financial Markets Worldwide

Rosetta Genomics Ltd (ROSGQ)

OTC Markets
Currency in USD
0.0001
0.0000(0.00%)
Closed·
ROSGQ Scorecard
Full Analysis
Stock generally trades with high price volatility
Trading near 52-week High
Fair Value
Unlock Value
Day's Range
0.00010.0001
52 wk Range
0.00010.0001
Key Statistics
Edit
Prev. Close
0.0001
Open
0.0001
Day's Range
0.0001-0.0001
52 wk Range
0.0001-0.0001
Volume
-
Average Volume (3m)
8.7K
1-Year Change
0%
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ROSGQ Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Technical Analysis
Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Unlock All 8
Suffers from weak gross profit margins
Unlock InvestingPro

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Strong Sell

Rosetta Genomics Ltd Company Profile

Rosetta Genomics Ltd. operates as a genomic diagnostics company worldwide. The company’s microRNA technologies based diagnostic tests include RosettaGX Cancer Origin for the identification of the primary site of metastatic cancer; mi-KIDNEY, a kidney tumor classification test for pathology samples; RosettaGX Reveal for the diagnosis of indeterminate thyroid fine-needle aspirate samples; and mi-LUNG diagnostic tests. It also provides UroVysion, a urine-based Fluorescence In Situ Hybridization (FISH) assay that is intended for use in conjunction with and not in lieu of current standard diagnostic procedures, as an aid for initial diagnosis of bladder carcinoma in patients with hematuria and subsequent monitoring for tumor recurrence in patients previously diagnosed with bladder cancer; and ERG/PTEN, which are FISH-based prognostic tests in prostate cancer. In addition, the company offers ALK/ROS1 that are FISH-based predictive tests indicated for patients who are diagnosed with late stage lung cancer; and PCR gene mutation analysis for bladder, lung, colon, and melanoma patients. The company provides its diagnostic solutions for oncologists, urologists, endocrinologists, cytopathologists, and other specialists to facilitate them in serving their patients. It has a license agreement with Max Planck Innovation GmbH for the rights to its proprietary microRNAs for diagnostics and research purposes. The company also has a collaboration agreement with Meir Medical Center to develop a microRNA classifier relating to patients with non-small cell lung cancer considered for treatment with immuno oncology drugs. Rosetta Genomics Ltd. was founded in 2000 and is headquartered in Rehovot, Israel.

Industry
Biotechnology & Medical Research
Sector
Healthcare
Employees
86
Market
United States

Compare ROSGQ to Peers and Sector

Metrics to compare
ROSGQ
Peers
Sector
Relationship
P/E Ratio
0.0x−2.7x−0.5x
PEG Ratio
0.00−0.040.00
Price/Book
0.0x2.1x2.6x
Price / LTM Sales
0.0x204.6x3.3x
Upside (Analyst Target)
0.0%589.7%45.4%
Fair Value Upside
Unlock−0.8%7.7%Unlock

Earnings

Latest Release
Dec 18, 2024
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
a
a
Unlock
Last 90 days

ROSGQ Income Statement

FAQ

What Stock Exchange Does Rosetta Genomics Trade On?

Rosetta Genomics is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Rosetta Genomics?

The stock symbol for Rosetta Genomics is "ROSGQ."

What Is the Rosetta Genomics Market Cap?

As of today, Rosetta Genomics market cap is 592.00.

What Is Rosetta Genomics's Earnings Per Share (TTM)?

The Rosetta Genomics EPS (TTM) is -4.54.

From a Technical Analysis Perspective, Is ROSGQ a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Rosetta Genomics Stock Split?

Rosetta Genomics has split 3 times.

How Many Employees Does Rosetta Genomics Have?

Rosetta Genomics has 86 employees.

What is the current trading status of Rosetta Genomics (ROSGQ)?

As of 03 Aug 2025, Rosetta Genomics (ROSGQ) is trading at a price of 0.00, with a previous close of 0.00. The stock has fluctuated within a day range of 0.00 to 0.00, while its 52-week range spans from 0.00 to 0.00.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.